))
From Neuroscientist to Biotech Innovator ft.Anita Scheuber
Manage episode 437688027 series 3557116
Content provided by Charles Spence. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Charles Spence or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Leadership and Diversity in Drug Development with Anita Scheuber.
In this episode, Charles talks with Anita Scheuber,the SVP of clinical development at Nimbus Therapeutics—a biotech firm using computational technology to develop medicines. She shares their pioneering work in AI-targeted drug discovery and her experience co-founding the biotech startup Hestia.
Anita highlights how different backgrounds help solve problems, the value of mentorship, and how to beat feelings of being an imposter. She also shares tips for strong leadership and gives guidance to budding biotech entrepreneurs.
Here's what you're in:
01:01 Anita's Journey to the U.S.
02:35 Switching from Neuroscience to Oncology
07:56 Joining Nimbus Therapeutics
10:07 Why Workplace Diversity Matters
14:56 Founding Hestia-A Startup biotech
24:40 Leadership and Personal Growth
30:14 Advice for Aspiring Entrepreneurs
32:16 Final Thoughts and Conclusion
About Anita Scheuber
Anita Scheuber brings over 15 years of pharmaceutical industry experience to Nimbus, specializing in oncology clinical development. Her expertise spans small molecule and immuno-oncology drug development across various stages and tumor types. She has held leadership positions at Trillium Therapeutics, Boston Pharmaceuticals, Pfizer, and GSK. She holds an M.D. from the University of Zurich and a Ph.D. in Neurosciences from Sorbonne University, with additional training at Harvard Medical School and Swiss hospitals.
Connect with Guest
LinkedIn: https://www.linkedin.com/in/anita-scheuber-8a1a8220/
Website: https://www.nimbustx.com/
About Charles
Charles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry. He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea), and also spent years doing diabetes research. After doing research and travel, a career in business and science felt the most appropriate.
In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East Coast and DACH.
Connect with Charles:
LinkedIn:https://www.linkedin.com/in/charles-spence-clinical/
Website: https://www.discera-search.com/
27 episoade
Distribuie
